Intuitive Surgical (NASDAQ:ISRG) Price Target Cut to $454.00 by Analysts at BTIG Research

Posted by Geri Gentry on Oct 13th, 2026

Intuitive Surgical (NASDAQ:ISRG – Free Report) had its target price decreased by BTIG Research from $469.00 to $454.00 in a research report report published on Monday, Marketbeat reports. BTIG Research currently has a buy rating on the medical equipment provider’s stock.

A number of other research analysts have also issued reports on the company. HSBC lowered Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price objective for the company. in a research report on Thursday, July 30th. Piper Sandler reaffirmed an “overweight” rating on shares of Intuitive Surgical in a research report on Friday, August 21st. KeyCorp reaffirmed an “overweight” rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. Oppenheimer upgraded Intuitive Surgical from a “market perform” rating to an “outperform” rating and set a $500.00 target price on the stock in a research note on Wednesday, August 12th. Finally, BMO Capital Markets reissued an “outperform” rating on shares of Intuitive Surgical in a report on Monday, July 20th. One analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $501.98.

Check Out Our Latest Report on Intuitive Surgical

Intuitive Surgical Stock Up 0.9%

Shares of ISRG stock opened at $427.64 on Monday. The business has a 50 day moving average of $387.41 and a two-hundred day moving average of $410.47. Intuitive Surgical has a 52 week low of $328.57 and a 52 week high of $603.88. The company has a market cap of $151.08 billion, a P/E ratio of 48.99, a PEG ratio of 3.20 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.48 by $0.32. The company had revenue of $2.89 billion during the quarter, compared to analyst estimates of $2.83 billion. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%. The business’s revenue was up 18.4% compared to the same quarter last year. During the same period in the prior year, the company earned $1.81 earnings per share. Analysts expect that Intuitive Surgical will post 8.87 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Director Amy Ladd sold 72 shares of the company’s stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $393.10, for a total value of $28,303.20. Following the completion of the sale, the director owned 179 shares in the company, valued at $70,364.90. This represents a 28.69% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $379.00, for a total value of $151,600.00. Following the transaction, the executive vice president directly owned 5,320 shares of the company’s stock, valued at $2,016,280. This represents a 6.99% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 12,370 shares of company stock worth $4,891,989. 0.60% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. 3Chopt Investment Partners LLC increased its position in Intuitive Surgical by 5.2% in the 1st quarter. 3Chopt Investment Partners LLC now owns 462 shares of the medical equipment provider’s stock worth $213,000 after purchasing an additional 23 shares during the last quarter. Vermillion Wealth Management Inc. lifted its holdings in shares of Intuitive Surgical by 58.1% during the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock valued at $31,000 after buying an additional 25 shares during the last quarter. W.G. Shaheen & Associates DBA Whitney & Co lifted its holdings in shares of Intuitive Surgical by 1.0% during the 1st quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 2,542 shares of the medical equipment provider’s stock valued at $1,172,000 after buying an additional 25 shares during the last quarter. Blue Fin Capital Inc. lifted its holdings in shares of Intuitive Surgical by 0.5% during the 1st quarter. Blue Fin Capital Inc. now owns 4,794 shares of the medical equipment provider’s stock valued at $2,210,000 after buying an additional 25 shares during the last quarter. Finally, Red Spruce Capital LLC grew its stake in shares of Intuitive Surgical by 4.1% in the 2nd quarter. Red Spruce Capital LLC now owns 640 shares of the medical equipment provider’s stock valued at $255,000 after buying an additional 25 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

(Get Free Report)

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.